Despite the fact that Pradaxa can cause uncontrollable, irreversible bleeding that can lead to fatal consequences, prominent heart specialists are still recommending it to their patients. Some, like Dr. Keith Churchwell, who heads up the Heart and Vascular Institute at Vanderbilt University, are a bit more cautious about it. Others, such as Dr. George Crossley, feel that reports of the dangers of Pradaxa have been exaggerated.
It's official: drugmaker Boehringer-Ingelheim (B-I) is pleased to announce that Pradaxa (dabigatran) has been affirmed by the FDA to be more effective in preventing strokes than the old standby, warfarin (Coumadin).
It's something they are crowing about in their latest press release. The latest update to the prescribing information included with the package now assures patients that Pradaxa is “superior in reducing ischemic and hemorrhagic strokes relative to warfarin.”
We know why doctors like Pradaxa (dabigotran) it’s been pointed out in several media sources and professional journals, the number of possible harmful interactions with other medications is far less than with other anti-clotting medications, such as warfarin. This is an important issue with geriatric patients, who are often on numerous medications for a variety of age-related conditions. Doctors can simply prescribe it and not worry about constant monitoring.
In May of 2012, a woman in Texarkana, TX filed an injury lawsuit against Boston Scientific over the vaginal sling that was implanted in her body two years ago to address the symptoms of stress incontinence (bladder control). After the surgery, she began experiencing unusual pain and bleeding as well as a condition known as dyspareunia, which adversely affects intimacy. She's suing for compensatory damages, punitive damages, exemplary damages, incidental damages, consequential damages, attorney's fees, and court costs.
Does anyone remember that great Jimmy Van Heusen-Sammy Cahn song, Call Me Irresponsible, recorded by the late and legendary Frank Sinatra?
Recently, Pradaxa manufacturer Boehringer Ingelheim made a decision to lower its price it charges to the UK's National Health Service (NHS) by 13%. According to the company, the decision was to make Pradaxa cost “as affordable as possible in this tough financial climate,” enabling physicians to write prescriptions “based on clinical need, not cost.”
All out of the goodness of their corporate hearts, right?
We've all probably bumped our heads from time to time with consequences no more serious than a bruise and or knot. However, for an 83-year-old Utah man, a small bump on the head turned out to be fatal.
Dabigatran, sold under the commercial brand name Pradaxa, has been considered to be a miracle cure when it comes to preventing stroke. It is an alternative to warfarin (sold as Coumadin, Jantoven and other brand names), which has numerous side effects ranging from hemorrhaging and osteoporosis to gangrene as well as heparin, which also has a number of adverse effects including elevated blood pressure and heart rate with accompanying chest pains.
In addition to risks associated with hemorrhaging, a study published in the 9 January 2012 issue of Archives of Internal Medicine reports that patients taking dabigatran have a 33% greater chance of developing heart disease or experiencing cardiac arrest.
Currently, this drug is being investigated by the Food and Drug Administration, though the authors of the above-referenced study continue to insist that for certain patients suffering from arrhythmia, the benefits outweigh the risks.Individual case report may indicate that some of the patients who suffered severe bleeding were unaware of the increased risk.
Learn more about Pradaxa Side Effects